Value of CDX2, villin, and α-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma
- 1 September 2005
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 18 (9) , 1217-1222
- https://doi.org/10.1038/modpathol.3800407
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- mTOR: a protein kinase switching between life and deathPharmacological Research, 2004
- Development of Gastric Carcinoma from Intestinal Metaplasia in Cdx2-transgenic MiceCancer Research, 2004
- The role of Cdx proteins in intestinal development and cancerCancer Biology & Therapy, 2004
- CDX-2, a New Marker for Adenocarcinoma of Gastrointestinal OriginAdvances in Anatomic Pathology, 2004
- Malignant Non-Urothelial Neoplasms of the Urinary Bladder: A ReviewEuropean Urology, 2003
- Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Δ716 Cdx2+/− compound mutant miceNature Genetics, 2003
- The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut developmentGut, 2003
- Immunohistochemical Distinction Between Primary Adenocarcinoma of the Bladder and Secondary Colorectal AdenocarcinomaThe American Journal of Surgical Pathology, 2001
- The homeobox gene CDX2 in colorectal carcinoma: a genetic analysisBritish Journal of Cancer, 2001
- Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 casesHistopathology, 2000